SAVARA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.3 USD | +3.12% |
|
-10.60% | -8.51% |
| 21/05 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
| 09/05 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SAVARA INC. | Bio Therapeutic Drugs | +3.12% | -10.60% | -8.51% | +64.12% | -61.57% | 576M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- SVRA Stock
- Charts Savara Inc.
- Comparison Chart
